ROIVANT SCIENCES LTD. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.18 USD | +0.04% |
|
-1.49% | -0.18% |
| 04-05 | Arbutus Biopharma Obtains Favorable Court Order in Moderna Patent Lawsuit | MT |
| 04-04 | Moderna Suffers Setback in Lawsuit by Arbutus | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROIVANT SCIENCES LTD. | Other Pharmaceuticals | +0.13% | -1.49% | -0.18% | +22.51% | - | 9.01B |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ROIV Stock
- Charts Roivant Sciences Ltd.
- Comparison Chart
